Form SCHEDULE 13G/A Onconetix, Inc. Filed by: KEYSTONE CAPITAL PARTNERS, LLC
Filed on: November 5, 20
Related stories
Graham Corp Reports Quarterly Results for Period Ended September 30
A machine-generated LSEG summary says Graham Corp reported results for the quarter ended September 30; the supplied body contains no figures.
M impact | EQUITY | Nov 05, 2026, 08:11 PM UTC
Briscoe Group Expects Full-Year Net Profit After Tax Up to NZ$55M
M impact | EQUITY | Nov 05, 2026, 08:03 PM UTC
Global Stocks Fall as Chip Selloff Deepens on AI Spending Concerns
Global stocks fell Thursday as semiconductor shares sold off after weak Qualcomm earnings, while concerns about possible limits on AI infrastructure investment added pressure.
M impact | EQUITY | Nov 05, 2026, 08:03 PM UTC
Korro Bio Shares Fall 11% After Novo Nordisk Ends Collaboration
Korro Bio said Novo Nordisk terminated a research collaboration and license agreement. Korro Bio shares fell 11% to $14.88 midday Thursday, after rising about 86% year to date.
M impact | EQUITY | Nov 05, 2026, 08:02 PM UTC
Briscoe Group Ltd. 3Q Sales NZD174.4M
L impact | EQUITY | Nov 05, 2026, 08:02 PM UTC
US session market picture: S&P 500 -3.58%, Nasdaq 100 -5.06%; EUR/USD -0.07%, WTI +2.8%, NVDA leads volume
US session market picture. US index futures: S and P futures is down 3.58 percent, Nasdaq futures is down 5.06 percent, Dow futures is down 2.91 percent and Russell futures is down
M impact | EQUITY | Nov 05, 2026, 08:01 PM UTC